Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Diabetes Care|July 14, 2017
Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset PatientsBeverley M Shields, Maggie Shepherd, Michelle Hudson, et al.
Scientific Reports|May 8, 2024
Development of a clinical calculator to aid the identification of MODY in pediatric patients at the time of diabetes diagnosisBeverley M Shields, Annelie Carlsson, Kashyap Patel, et al.
BMJ Open Diabetes Research & Care|April 22, 2022
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter studyAnxious J Niwaha, Lauren R Rodgers, Alice L J Carr, et al.
Pediatric Diabetes|January 8, 2013
Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetesRachel E J Besser, Beverley M Shields, Suzanne E Hammersley, et al.
Diabetologia|April 11, 2019
Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetesNicholas J Thomas, Anita L Lynam, Anita V Hill, et al.
BMC Medicine|August 20, 2021
Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort studyLauren R Rodgers, Anita V Hill, John M Dennis, et al.
BMJ Open Diabetes Research & Care|September 18, 2021
HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter studyAnxious J Niwaha, Lauren R Rodgers, Rosamund Greiner, et al.
Diabetes|February 22, 2018
Fetal Genotype and Maternal Glucose Have Independent and Additive Effects on Birth WeightAlice E Hughes, Michael Nodzenski, Robin N Beaumont, et al.
Diabetes, Obesity & Metabolism|March 5, 2019
Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017John M Dennis, William E Henley, Andrew P McGovern, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 25, 2012
Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetesTim J McDonald, Jane McEneny, Ewan R Pearson, et al.
Pageof 12